financetom
Business
financetom
/
Business
/
Exxon Mobil Trades Flat As Investors Await Q3 Earnings Report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exxon Mobil Trades Flat As Investors Await Q3 Earnings Report
Oct 30, 2025 1:33 PM

Exxon Mobil Corp ( XOM ) shares were little changed Thursday afternoon as the market paused ahead of the energy giant's third-quarter earnings release, scheduled for before the opening bell on Friday. Here’s what investors need to know.

Get the inside scoop on XOM stock here.

What To Know: Analysts are anticipating a strong quarter, with consensus estimates projecting earnings of $1.81 per share on revenues of $84.87 billion. A conference call with executives is set for 9:30 a.m. ET.

The company enters its earnings report with several positive tailwinds. The stock benefited recently from a sector-wide rally after U.S. sanctions against Russian oil producers helped push crude prices higher, which directly boosts Exxon's profitability.

Strategically, Exxon has been expanding its global footprint, recently securing its first-ever sale of Guyanese crude oil to refiners in India, a key growth market.

Wall Street sentiment remains largely positive, with firms such as Wells Fargo and UBS recently issuing or maintaining bullish ratings. Investors now await Friday's results and management's outlook for further direction.

Benzinga Edge Rankings: Benzinga Edge Rankings highlight the stock’s strong fundamentals, giving it a high Value score of 76.89 and a solid Growth score of 67.61.

XOM Price Action: Exxon shares were down 1.57% at $114.69 at the time of publication on Thursday, according to data from Benzinga Pro. The stock is trading within its 52-week range of $97.80 to $123.21. Despite this pullback, Exxon has shown a solid year-to-date performance, up 7.7%, indicating resilience in a fluctuating market.

Currently, Exxon is trading approximately 2.3% above its 50-day moving average of $112.96 and about 5% above its 200-day moving average of $110.01. These moving averages suggest a bullish trend in the medium to long term, providing a supportive backdrop for the stock.

The relative strength index (RSI) stands at 61.31, signaling a neutral position, which may indicate that the stock is neither overbought nor oversold at this time.

Read Also: Meta Tumbles 10%, Google Marks Historic Rally: What’s Moving Markets Thursday?

How To Buy XOM Stock

Besides going to a brokerage platform to purchase a share — or fractional share — of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, Exxon Mobil ( XOM ) is in the Energy sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CrowdStrike Q4 Earnings: Revenue Beat, EPS Beat, 'Strong Momentum,' Shares Slide On Soft Guidance
CrowdStrike Q4 Earnings: Revenue Beat, EPS Beat, 'Strong Momentum,' Shares Slide On Soft Guidance
Mar 4, 2025
CrowdStrike Holdings Inc ( CRWD ) reported financial results for the fourth quarter Tuesday after the bell. Here’s a look at the key metrics from the report. Q4 Earnings: CrowdStrike ( CRWD ) reported fourth-quarter revenue of $1.058 billion, beating the consensus estimate of $1.032 billion. The cybersecurity company reported adjusted earnings of $1.03 per share, beating analyst estimates of 85 cents per...
Cricut Q4 Earnings Rise, Revenue Falls
Cricut Q4 Earnings Rise, Revenue Falls
Mar 4, 2025
04:32 PM EST, 03/04/2025 (MT Newswires) -- Cricut ( CRCT ) reported Q4 earnings late Tuesday of $0.06 per diluted share, up from $0.05 a year earlier. Analyst polled by FactSet expected $0.04. Revenue for the quarter ended Dec. 31 was $209.3 million, down from $231.2 million a year earlier. Two analysts polled by FactSet expected $214.4 million. ...
Marsh & Mclennan Companies Insider Sold Shares Worth $871,151, According to a Recent SEC Filing
Marsh & Mclennan Companies Insider Sold Shares Worth $871,151, According to a Recent SEC Filing
Mar 4, 2025
04:31 PM EST, 03/04/2025 (MT Newswires) -- Nicholas Mark Studer, President and CEO of Oliver Wyman Group, on February 28, 2025, sold 3,649 shares in Marsh & Mclennan Companies ( MMC ) for $871,151. Following the Form 4 filing with the SEC, Studer has control over a total of 10,724 common shares of the company, with 10,724 shares held directly....
U.S. FDA places BioNTech's malaria vaccine study on clinical hold
U.S. FDA places BioNTech's malaria vaccine study on clinical hold
Mar 4, 2025
March 4 (Reuters) - The U.S. Food and Drug Administration has placed a clinical hold on BioNTech's early-to-mid stage trial of an experimental malaria vaccine, the drugmaker said in a filing, sending its U.S.-listed shares down 1.5% after the bell on Tuesday. The trial was to evaluate the safety and efficacy of the RNA-based vaccine called BNT165e for prevention of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved